Thursday, October 30, 2025 2:06:00 PM
Investor082,
Funny that you think there will be an approval but that when that happens BPs will stay away. Do you think BP investors will stay away when they realize their company products are second rate at that point? Do you think they will ignore the advances made with manufacturing by NWBO or that Linda won’t point this out to them and others or that checkpoint inhibitors in generic form will be coming on line in less than 3 years?
In order for your scenario to play out the investors in big pharma must remain ignorant including the institutional support they have. Do you not think that the link between the 7 market makers accused of fraud and their big pharma investments won’t become an issue once made more public with an approval? When NWBO receives the approval that you said you expect who will be viewed as the one with greatest upside potential, NWBO or the big pharmas? There are many questions that seem to have fairly obvious answers that your negative assumptions ignore. Ignorance is bliss until it’s not. Best wishes.
Funny that you think there will be an approval but that when that happens BPs will stay away. Do you think BP investors will stay away when they realize their company products are second rate at that point? Do you think they will ignore the advances made with manufacturing by NWBO or that Linda won’t point this out to them and others or that checkpoint inhibitors in generic form will be coming on line in less than 3 years?
In order for your scenario to play out the investors in big pharma must remain ignorant including the institutional support they have. Do you not think that the link between the 7 market makers accused of fraud and their big pharma investments won’t become an issue once made more public with an approval? When NWBO receives the approval that you said you expect who will be viewed as the one with greatest upside potential, NWBO or the big pharmas? There are many questions that seem to have fairly obvious answers that your negative assumptions ignore. Ignorance is bliss until it’s not. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
